Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2025-08-26 00:00:00 ET · period of report 2025-08-22 · accession 0001231615-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2025-08-26 | 2025-08-22+ | AXSM | JEFFS ROGER | Dir | S - Sale | $120.05 | -36.7K | 151.0K | -20% | -$4.41M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-26 | S | D | 20,000 | $120.03 | 130,974 | D | — | — | (F4) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $120.00 and $120.26. |
| 2 | Common | Common Stock | 2025-08-22 | S | D | 16,694 | $120.08 | 150,974 | D | — | — | (F3) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $120.00 and $120.34. |